GIM
AZN icon

Guild Investment Management’s AstraZeneca AZN Stock Holding History

Guild Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-23,528
Closed -$2.34M – 67
2021
Q1 		$2.34M Buy
23,528
+2,968
+14% +$298K 2.51% 14
2020
Q4 		$2.06M Buy
20,560
+10,975
+115% +$1.16M 2.26% 17
2020
Q3 		$1.05M Sell
9,585
-915
-9% -$102K 1.45% 27
2020
Q2 		$1.11M Buy
10,500
+535
+5% +$55.3K 1.58% 27
2020
Q1 		$890K Sell
9,965
-1,225
-11% -$115K 1.93% 22
2019
Q4 		$1.12M Buy
+11,190
New +$1.05M 1.43% 29

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Guild Investment Management's AZN Position: Q2 2021 in Review

Guild Investment Management sold out of AstraZeneca (AZN) in Q2 2021, closing a stake of 23,528 shares — an estimated $2.34M sold.

Guild Investment Management first reported a position in AZN in Q4 2019 and held it in 6 quarters. The position peaked at $2.34M in Q1 2021. 771 funds tracked by Wall St. Rank hold AZN as of Q2 2021.

  • Guild Investment Management reported no remaining AstraZeneca position as of Q2 2021 after selling out during the quarter.
  • Guild Investment Management sold 23,528 AstraZeneca shares in Q2 2021, an estimated $2.34M.
  • Guild Investment Management first reported a position in AstraZeneca in Q4 2019 and held it in 6 quarters.
  • Guild Investment Management's AstraZeneca position peaked at $2.34M in Q1 2021.
  • 771 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2021.

Based on Guild Investment Management's 13F filing for Q2 2021, filed 28 Jul 2021.